{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:47:50Z","timestamp":1759402070704,"version":"build-2065373602"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007546","name":"Agence Nationale de S\u00e9curit\u00e9 Sanitaire de l\u2019Alimentation, de l\u2019Environnement et du Travail","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007546","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007204","name":"Centre de Coop\u00e9ration Internationale en Recherche Agronomique pour le D\u00e9veloppement","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007204","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.vaccine.2014.10.088","type":"journal-article","created":{"date-parts":[[2014,11,10]],"date-time":"2014-11-10T23:05:16Z","timestamp":1415660716000},"page":"141-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["An adenoviral vector expressing lipoprotein A, a major antigen of Mycoplasma mycoides subspecies mycoides, elicits robust immune responses in mice"],"prefix":"10.1016","volume":"33","author":[{"given":"Marl\u00e8ne","family":"Carozza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Unterfinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Galea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muriel","family":"Coulpier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Klonjkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Thiaucourt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Tott\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.10.088_bib0005","doi-asserted-by":"crossref","first-page":"999","DOI":"10.20506\/rst.25.3.1710","article-title":"An estimation of the economic impact of contagious bovine pleuropneumonia in Africa","volume":"25","author":"Tambi","year":"2006","journal-title":"Rev Sci Tech Int Off Epizoot"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0010","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.prevetmed.2014.03.029","article-title":"Control of contagious bovine pleuropneumonia: knowledge, attitudes, perceptions and practices in Narok district of Kenya","volume":"115","author":"Kairu-Wanyoike","year":"2014","journal-title":"Prev Vet Med"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0015","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1749-6632.2000.tb05276.x","article-title":"Contagious bovine pleuropneumonia. A reassessment of the efficacy of vaccines used in Africa","volume":"916","author":"Thiaucourt","year":"2000","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0020","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.20506\/rst.15.4.991","article-title":"Contagious bovine pleuropneumonia vaccines: the current situation and the need for improvement","volume":"15","author":"Tulasne","year":"1996","journal-title":"Rev Sci Tech Int Off Epizoot"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0025","first-page":"615","article-title":"Experiments with an avianised strain of the organism of contagious bovine pleuropneumonia","volume":"64","author":"Sheriff","year":"1952","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0030","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1128\/IAI.00938-07","article-title":"Cytotoxicity of Mycoplasma mycoides subsp. mycoides small colony type to bovine epithelial cells","volume":"76","author":"Bischof","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0035","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1365-3083.2005.01690.x","article-title":"Mycoplasma mycoides ssp. mycoides biotype small colony-secreted components induce apoptotic cell death in bovine leucocytes","volume":"62","author":"Dedieu","year":"2005","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0040","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s11250-013-0429-9","article-title":"Recent observations on site reactions in cattle to vaccination against contagious bovine pleuropneumonia (CBPP) using T1\/44 vaccine in Zambia","volume":"46","author":"Muuka","year":"2014","journal-title":"Trop Anim Health Prod"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0045","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.vetmic.2003.11.007","article-title":"Contagious bovine pleuropneumonia (CBPP) caused by vaccine strain T1\/44 of Mycoplasma mycoides subsp. mycoides SC.","volume":"98","author":"Mbulu","year":"2004","journal-title":"Vet Microbiol"},{"year":"2006","series-title":"CBPP control: antibiotics to the rescue?","author":"FAO","key":"10.1016\/j.vaccine.2014.10.088_bib0050"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0055","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1297-9716-44-122","article-title":"Development of an improved vaccine for contagious bovine pleuropneumonia: an African perspective on challenges and proposed actions","volume":"44","author":"Jores","year":"2013","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0060","first-page":"99","article-title":"Contagious bovine pleuropneumonia vaccines and control strategies: recent data","volume":"119","author":"Thiaucourt","year":"2004","journal-title":"Dev Biol"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0065","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.vetimm.2005.04.011","article-title":"Gamma interferon-producing CD4 T-cells correlate with resistance to Mycoplasma mycoides subsp. mycoides S.C. infection in cattle","volume":"107","author":"Dedieu","year":"2005","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0070","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1051\/vetres:2006020","article-title":"Characterisation of the lymph node immune response following Mycoplasma mycoides subsp. Mycoides SC infection in cattle.","volume":"37","author":"Dedieu","year":"2006","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0075","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1051\/vetres:2007046","article-title":"Analysis of cellular responses to Mycoplasma mycoides subsp. mycoides small colony biotype associated with control of contagious bovine pleuropneumonia","volume":"39","author":"Totte","year":"2008","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0080","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1051\/vetres:2006032","article-title":"Pulmonary and serum antibody responses elicited in zebu cattle experimentally infected with Mycoplasma mycoides subsp. mycoides SC by contact exposure","volume":"37","author":"Niang","year":"2006","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0085","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1128\/CDLI.7.4.588-595.2000","article-title":"Antigenic and genetic characterization of lipoprotein LppQ from Mycoplasma mycoides subsp. mycoides SC","volume":"7","author":"Abdo","year":"2000","journal-title":"Clin Diagn Lab Immunol"},{"issue":"Pt 12","key":"10.1016\/j.vaccine.2014.10.088_bib0090","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1099\/13500872-142-12-3515","article-title":"Characterization of the gene for an immunodominant 72kDa lipoprotein of Mycoplasma mycoides subsp. mycoides small colony type","volume":"142","author":"Cheng","year":"1996","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0095","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1051\/vetres:2003035","article-title":"Antigenic and genetic characterisation of lipoprotein lppC from Mycoplasma mycoides subsp. mycoides SC","volume":"34","author":"Pilo","year":"2003","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0100","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cimid.2008.08.011","article-title":"Comparative analysis of four lipoproteins from Mycoplasma mycoides subsp. mycoides Small Colony identifies LppA as a major T-cell antigen","volume":"33","author":"Dedieu","year":"2010","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0105","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.dci.2009.09.005","article-title":"CD62L defines a subset of pathogen-specific bovine CD4 with central memory cell characteristics","volume":"34","author":"Totte","year":"2010","journal-title":"Dev Comp Immunol"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0110","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1099\/0022-1317-36-1-59","article-title":"Characteristics of a human cell line transformed by DNA from human adenovirus type 5","volume":"36","author":"Graham","year":"1977","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0115","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1126\/science.275.5304.1320","article-title":"Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5","volume":"275","author":"Bergelson","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0120","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1101\/gr.1673304","article-title":"The genome sequence of Mycoplasma mycoides subsp. mycoides SC type strain PG1 T, the causative agent of contagious bovine pleuropneumonia (CBPP)","volume":"14","author":"Westberg","year":"2004","journal-title":"Genome Res"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0125","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1016\/j.vaccine.2011.06.071","article-title":"Antigen encoded by vaccine vectors derived from human adenovirus serotype 5 is preferentially presented to CD8+ T lymphocytes by the CD8alpha+ dendritic cell subset","volume":"29","author":"Suleman","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0130","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1128\/jvi.70.7.4805-4810.1996","article-title":"Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli","volume":"70","author":"Chartier","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0135","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S1525-0016(03)00213-2","article-title":"Metabolically biotinylated adenovirus for cell targeting, ligand screening, and vector purification","volume":"8","author":"Parrott","year":"2003","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0140","first-page":"3","article-title":"Production and purification of non replicative canine adenovirus type 2 derived vectors","volume":"5083","author":"Szelechowski","year":"2013","journal-title":"J Vis Exp JoVE"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0145","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0042-6822(68)90121-9","article-title":"The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12","volume":"36","author":"Maizel","year":"1968","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0150","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jim.2006.07.027","article-title":"A cost effective non-commercial ECL-solution for Western blot detections yielding strong signals and low background","volume":"318","author":"Haan","year":"2007","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0155","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0160","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4049\/jimmunol.176.1.200","article-title":"The CD8+ T cell population elicited by recombinant adenovirus displays a novel partially exhausted phenotype associated with prolonged antigen presentation that nonetheless provides long-term immunity","volume":"176","author":"Yang","year":"2006","journal-title":"J Immunol (Baltim MD 1950)"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0165","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nri2097","article-title":"T(H)1 cells control themselves by producing interleukin-10","volume":"7","author":"O\u2019Garra","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0170","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1084\/jem.20092532","article-title":"IL-10 production differentially influences the magnitude, quality, and protective capacity of Th1 responses depending on the vaccine platform","volume":"207","author":"Darrah","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0175","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1089\/10430349950018364","article-title":"Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo","volume":"10","author":"Muruve","year":"1999","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0180","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cimid.2007.07.009","article-title":"Contagious bovine pleuropneumonia: a rationale for the development of a mucosal sub-unit vaccine","volume":"31","author":"Dedieu-Engelmann","year":"2008","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0185","doi-asserted-by":"crossref","first-page":"10078","DOI":"10.1128\/JVI.77.18.10078-10087.2003","article-title":"Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system","volume":"77","author":"Lemiale","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0190","doi-asserted-by":"crossref","first-page":"6357","DOI":"10.4049\/jimmunol.173.10.6357","article-title":"Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis","volume":"173","author":"Wang","year":"2004","journal-title":"J Immunol (Baltim MD 1950)"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0195","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.4049\/jimmunol.181.6.4188","article-title":"Trafficking of antigen-specific CD8+ T lymphocytes to mucosal surfaces following intramuscular vaccination","volume":"181","author":"Kaufman","year":"2008","journal-title":"J Immunol (Baltim MD 1950)"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0200","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/j.vaccine.2006.11.044","article-title":"Intramuscular rather than oral administration of replication-defective adenoviral vaccine vector induces specific CD8+ T cell responses in the gut","volume":"25","author":"Lin","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0205","doi-asserted-by":"crossref","first-page":"205ra134","DOI":"10.1126\/scitranslmed.3006843","article-title":"A human type 5 adenovirus-based tuberculosis vaccine induces robust T cell responses in humans despite preexisting anti-adenovirus immunity","volume":"5","author":"Smaill","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0210","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.3390\/v4112711","article-title":"Advances and future challenges in recombinant adenoviral vectored H5N1 influenza vaccines","volume":"4","author":"Zhang","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0215","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.vaccine.2013.11.045","article-title":"Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-priming and boosting with adenovirus or protein based vaccines","volume":"32","author":"Dean","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0220","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1128\/IAI.00287-09","article-title":"Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis","volume":"77","author":"Vordermeier","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0225","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0264-410X(01)00458-3","article-title":"Induction of protective immunity to bovine herpesvirus type 1 in cattle by intranasal administration of replication-defective human adenovirus type 5 expressing glycoprotein gC or gD","volume":"20","author":"Gogev","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0230","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1016\/j.vaccine.2011.05.025","article-title":"International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations","volume":"29","author":"Barouch","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0235","doi-asserted-by":"crossref","first-page":"10522","DOI":"10.1128\/JVI.00450-10","article-title":"Adenovirus-based vaccines: comparison of vectors from three species of adenoviridae","volume":"84","author":"Chen","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0240","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.vaccine.2009.10.145","article-title":"International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: correlates of high Ad5 titers and implications for potential HIV vaccine trials","volume":"28","author":"Mast","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0245","doi-asserted-by":"crossref","first-page":"115ra2","DOI":"10.1126\/scitranslmed.3002925","article-title":"Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species","volume":"4","author":"Colloca","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0250","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1006\/viro.2000.0350","article-title":"Circumvention of vector-specific neutralizing antibody response by alternating use of human and non-human adenoviruses: implications in gene therapy","volume":"272","author":"Moffatt","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2014.10.088_bib0255","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/gt.2010.1","article-title":"Evaluation of cross-reactive cell-mediated immune responses among human, bovine and porcine adenoviruses","volume":"17","author":"Sharma","year":"2010","journal-title":"Gene Ther"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14015072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14015072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:21:08Z","timestamp":1759400468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14015072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0264410X14015072"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.10.088","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An adenoviral vector expressing lipoprotein A, a major antigen of Mycoplasma mycoides subspecies mycoides, elicits robust immune responses in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.10.088","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}